Program
MG-K10 Humanized Monoclonal Antibody Injection
Also written as “MG-K10 humanized monoclonal antibody injection”.
Its studies are mostly in Dermatitis, Atopic · Chronic Urticaria, led by Shanghai Mabgeek Biotech..
Furthest: phase 3, since Mar 11, 20263 company-led studies, 3 open or runningNext primary completion: Dec 2027 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Shanghai Mabgeek Biotech. | 33 open or running | phase 3since Mar 11, 2026 | Mar 11, 2026 | Dec 2027phase 2 · NCT07938606 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 11, 2026First studies: 2 phase 3 studiesFirst studyNCT07479615, NCT07546487
- Oct 27, 2026Phase 2 study in Dermatitis, AtopicNCT07938606 · 24 planned · China
Ahead
- Dec 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07938606
- Mar 31, 2028Primary completion: phase 3 study in Chronic UrticariaNCT07546487
- Jan 2029Primary completion: phase 3 study in Dermatitis, AtopicNCT07479615
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07938606Dermatitis, Atopic · China | 2 | Not yet recruiting | Dec 2027 | 24 |
| NCT07546487Chronic Urticaria | 3 | Not yet recruiting | Mar 31, 2028 | 226 |
| NCT07479615Dermatitis, Atopic | 3 | Not yet recruiting | Jan 2029 | 498 |
How it is read
Names in the registry
- “MG-K10 Humanized Monoclonal Antibody Injection”, 2 entries
- “MG-K10 humanized monoclonal antibody injection”, 1 entry
Conditions, from the studies’ own filings
- Dermatitis, Atopic, 2 studies
- Chronic Urticaria, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.